Standard Biotools Stock Market Value

LAB Stock  USD 1.26  0.02  1.61%   
Standard Biotools' market value is the price at which a share of Standard Biotools trades on a public exchange. It measures the collective expectations of Standard Biotools investors about its performance. Standard Biotools is trading at 1.26 as of the 8th of February 2026, a 1.61 percent increase since the beginning of the trading day. The stock's open price was 1.24.
With this module, you can estimate the performance of a buy and hold strategy of Standard Biotools and determine expected loss or profit from investing in Standard Biotools over a given investment horizon. Check out Standard Biotools Correlation, Standard Biotools Volatility and Standard Biotools Performance module to complement your research on Standard Biotools.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
Symbol

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.39)
Revenue Per Share
0.448
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.15)
Return On Equity
(0.33)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Standard Biotools 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Standard Biotools' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Standard Biotools.
0.00
11/10/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/08/2026
0.00
If you would invest  0.00  in Standard Biotools on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Standard Biotools or generate 0.0% return on investment in Standard Biotools over 90 days. Standard Biotools is related to or competes with Varex Imaging, CeriBell, Cullinan Oncology, Avanos Medical, So Young, ADC Therapeutics, and Treace Medical. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researche... More

Standard Biotools Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Standard Biotools' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Standard Biotools upside and downside potential and time the market with a certain degree of confidence.

Standard Biotools Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Standard Biotools' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Standard Biotools' standard deviation. In reality, there are many statistical measures that can use Standard Biotools historical prices to predict the future Standard Biotools' volatility.
Hype
Prediction
LowEstimatedHigh
0.061.285.75
Details
Intrinsic
Valuation
LowRealHigh
0.071.345.81
Details
3 Analysts
Consensus
LowTargetHigh
1.411.551.72
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.01-0.01-0.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Standard Biotools. Your research has to be compared to or analyzed against Standard Biotools' peers to derive any actionable benefits. When done correctly, Standard Biotools' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Standard Biotools.

Standard Biotools February 8, 2026 Technical Indicators

Standard Biotools Backtested Returns

Standard Biotools appears to be dangerous, given 3 months investment horizon. Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.048, which indicates the firm had a 0.048 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Standard Biotools, which you can use to evaluate the volatility of the company. Please review Standard Biotools' Risk Adjusted Performance of 0.0294, coefficient of variation of 3792.87, and Semi Deviation of 3.36 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Standard Biotools holds a performance score of 3. The entity has a beta of 1.29, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Standard Biotools will likely underperform. Please check Standard Biotools' jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Standard Biotools' existing price patterns will revert.

Auto-correlation

    
  0.13  

Insignificant predictability

Standard Biotools has insignificant predictability. Overlapping area represents the amount of predictability between Standard Biotools time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Standard Biotools price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Standard Biotools price fluctuation can be explain by its past prices.
Correlation Coefficient0.13
Spearman Rank Test-0.01
Residual Average0.0
Price Variance0.02

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Standard Biotools Correlation, Standard Biotools Volatility and Standard Biotools Performance module to complement your research on Standard Biotools.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Standard Biotools technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Standard Biotools trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...